Ligand validation:3KZI

SQD: 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL

SQD is a Ligand Of Interest in 3KZI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3KZI_SQD_D_361	13%	4%	0.294	0.871	2.57	2.94	19	15	9	0	80%	1
3KZI_SQD_C_475	2%	5%	0.426	0.743	2.59	2.75	26	18	8	0	94%	1
3KZI_SQD_L_213	1%	5%	0.584	0.727	2.6	2.88	24	19	2	0	87%	1
3KZI_SQD_F_224	0%	4%	0.805	0.532	2.65	2.85	21	19	0	0	83%	1
5V2C_SQD_a_413	94%	21%	0.075	0.976	1.12	2.14	4	12	0	0	100%	1
5GTI_SQD_A_409	91%	29%	0.066	0.95	0.98	1.84	3	13	0	0	100%	1
5WS6_SQD_A_411	87%	32%	0.084	0.954	0.88	1.78	2	12	0	0	100%	1
6DHE_SQD_A_412	78%	20%	0.113	0.961	1.05	2.27	5	14	0	0	96%	1
8IRC_SQD_a_411	77%	29%	0.119	0.96	0.96	1.83	3	13	0	0	100%	1
8IR5_SQD_a_411	76%	31%	0.123	0.958	0.95	1.77	3	13	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.